Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
The Pharmacogenomics Journal|January 25, 2017
Cost-effectiveness of cytochrome P450 2C19 *2 genotype-guided selection of clopidogrel or ticagrelor in Chinese patients with acute coronary syndromeY Wang, B P Yan, D Liew, et al.Heart Asia|June 22, 2016
Current endovascular therapy for lower extremity peripheral arterial disease: indications, outcomes and modalitiesB P Yan, T J Kiernan, Y-Y Lam, et al.International Journal of Cardiology|September 28, 2007
Spontaneous resolution of multiple coronary aneurysms complicating drug eluting stent implantationR Gurvitch, B P Yan, R Warren, et al.International Journal of Cardiology|July 9, 2016
Add-on tests for improving risk-stratification in emergency department patients with chest pain who are at low to moderate risk of 30-day major adverse cardiac eventsT H Rainer, Y K Leung, A Lee, et al.International Journal of Cardiology|April 7, 2009
Clinical outcomes of drug-eluting stent use in patients with ST elevation myocardial infarctionR Gurvitch, J Lefkovits, R J Warren, et al.Journal of Interventional Cardiology|May 21, 2009
Coronary artery perforations in the contemporary interventional eraT J Kiernan, B P Yan, N Ruggiero, et al.Internal Medicine Journal|March 11, 2014
Trends in door-to-balloon time and outcomes following primary percutaneous coronary intervention for ST-elevation myocardial infarction: an Australian perspectiveA L Brennan, N Andrianopoulos, S J Duffy, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|December 6, 2005
What is the best contemporary treatment for in-stent restenosis?Peter Barlis, Mark C G Horrigan, Robert K Chan, et al.Heart, Lung & Circulation|February 14, 2006
The foundation and launch of the Melbourne Interventional Group: a collaborative interventional cardiology projectA E Ajani, G Szto, S J Duffy, et al.Pageof 1